Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA.
George Washington Medical Faculty Associates, George Washington Cancer Center, Washington, DC, USA.
Gynecol Oncol. 2024 May;184:224-235. doi: 10.1016/j.ygyno.2024.02.005. Epub 2024 Feb 10.
We investigated racial disparities in survival by histology in cervical cancer and examined the factors contributing to these disparities.
Non-Hispanic Black and non-Hispanic White (hereafter known as Black and White) patients with stage I-IV cervical carcinoma diagnosed between 2004 and 2017 in the National Cancer Database were studied. Survival differences were compared using Cox modeling to estimate hazard ratio (HR) or adjusted HR (AHR) and 95% confidence interval (CI). The contribution of demographic, socioeconomic and clinical factors to the Black vs White differences in survival was estimated after applying propensity score weighting in patients with squamous cell carcinoma (SCC) or adenocarcinoma (AC).
This study included 10,111 Black and 43,252 White patients with cervical cancer. Black patients had worse survival than White cervical cancer patients (HR = 1.40, 95% CI = 1.35-1.45). Survival disparities between Black and White patients varied significantly by histology (HR = 1.20, 95% CI = 1.15-1.24 for SCC; HR = 2.32, 95% CI = 2.12-2.54 for AC, interaction p < 0.0001). After balancing the selected demographic, socioeconomic and clinical factors, survival in Black vs. White patients was no longer different in those with SCC (AHR = 1.01, 95% CI 0.97-1.06) or AC (AHR = 1.09, 95% CI = 0.96-1.24). In SCC, the largest contributors to survival disparities were neighborhood income and insurance. In AC, age was the most significant contributor followed by neighborhood income, insurance, and stage. Diagnosis of AC (but not SCC) at ≥65 years old was more common in Black vs. White patients (26% vs. 13%, respectively).
Histology matters in survival disparities and diagnosis at ≥65 years old between Black and White cervical cancer patients. These disparities were largely explained by modifiable factors.
本研究旨在调查宫颈癌患者的组织学生存差异,并探讨导致这些差异的因素。
本研究纳入了 2004 年至 2017 年间国家癌症数据库中诊断为 I-IV 期宫颈癌的非西班牙裔黑人和非西班牙裔白人(以下简称黑人和白人)患者。使用 Cox 模型比较生存差异,以估计风险比(HR)或调整后 HR(AHR)和 95%置信区间(CI)。在鳞状细胞癌(SCC)或腺癌(AC)患者中应用倾向评分加权后,估计人口统计学、社会经济学和临床因素对黑人和白人之间生存差异的贡献。
本研究纳入了 10111 名黑人患者和 43252 名白人患者。黑人患者的生存状况较白人患者差(HR=1.40,95%CI=1.35-1.45)。黑人和白人患者的生存差异在组织学上存在显著差异(HR=1.20,95%CI=1.15-1.24 用于 SCC;HR=2.32,95%CI=2.12-2.54 用于 AC,交互作用 p<0.0001)。在平衡了选定的人口统计学、社会经济学和临床因素后,SCC 患者中黑人和白人患者的生存差异不再存在(AHR=1.01,95%CI 0.97-1.06)或 AC(AHR=1.09,95%CI=0.96-1.24)。在 SCC 中,对生存差异贡献最大的是社区收入和保险。在 AC 中,年龄是最重要的贡献因素,其次是社区收入、保险和分期。在 65 岁及以上的患者中,诊断为 AC(而非 SCC)的黑人患者多于白人患者(分别为 26%和 13%)。
组织学在黑人和白人宫颈癌患者的生存差异和 65 岁及以上患者的诊断中起着重要作用。这些差异在很大程度上可以通过可改变的因素来解释。